Matches in Wikidata for { <http://www.wikidata.org/entity/Q91797066> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q91797066 description "articolo scientifico (pubblicato il 2020)" @default.
- Q91797066 description "artikull shkencor i botuar më 01 shkurt 2020" @default.
- Q91797066 description "artículu científicu espublizáu en febreru de 2020" @default.
- Q91797066 description "scientific article published on 01 February 2020" @default.
- Q91797066 description "wetenschappelijk artikel" @default.
- Q91797066 description "наукова стаття, опублікована 1 лютого 2020" @default.
- Q91797066 name "Evolving primary and secondary endpoints in randomized controlled trials leading to approval of biologics and small molecules in IBD: an historical perspective" @default.
- Q91797066 name "Evolving primary and secondary endpoints in randomized controlled trials leading to approval of biologics and small molecules in IBD: an historical perspective" @default.
- Q91797066 type Item @default.
- Q91797066 label "Evolving primary and secondary endpoints in randomized controlled trials leading to approval of biologics and small molecules in IBD: an historical perspective" @default.
- Q91797066 label "Evolving primary and secondary endpoints in randomized controlled trials leading to approval of biologics and small molecules in IBD: an historical perspective" @default.
- Q91797066 prefLabel "Evolving primary and secondary endpoints in randomized controlled trials leading to approval of biologics and small molecules in IBD: an historical perspective" @default.
- Q91797066 prefLabel "Evolving primary and secondary endpoints in randomized controlled trials leading to approval of biologics and small molecules in IBD: an historical perspective" @default.
- Q91797066 P1433 Q91797066-79C5873A-D40C-469B-A0F5-FCD75254659C @default.
- Q91797066 P1476 Q91797066-616EB12A-AEA0-466C-B8F7-9BECE3A3C3AC @default.
- Q91797066 P2093 Q91797066-58BEFF0E-AB64-422C-9428-B80654BA7105 @default.
- Q91797066 P2093 Q91797066-65C3D6B5-42C5-4794-A8BE-F9F508697D96 @default.
- Q91797066 P304 Q91797066-4AD742C9-032E-46AB-9B8E-0A5441404912 @default.
- Q91797066 P31 Q91797066-620922F3-83EE-49C6-9D5F-9A5DF17BC676 @default.
- Q91797066 P356 Q91797066-2EA8C705-5856-4E78-B0BB-300E2055439F @default.
- Q91797066 P433 Q91797066-9C9578F3-246A-4D1D-A3D3-DEECAF4768A7 @default.
- Q91797066 P478 Q91797066-59FE1910-5BEB-4D46-82C0-4B665AB13FCD @default.
- Q91797066 P50 Q91797066-4D28F71C-0D4A-4792-A916-A85C12405A90 @default.
- Q91797066 P50 Q91797066-8AB7037D-6B05-4C46-A56D-59020D1B1C1C @default.
- Q91797066 P577 Q91797066-67D525DD-632F-481B-B6C0-6199801FD901 @default.
- Q91797066 P698 Q91797066-5D27EB1F-6B7B-4C95-9327-A3A9BD110CA7 @default.
- Q91797066 P356 14712598.2020.1702020 @default.
- Q91797066 P698 31815548 @default.
- Q91797066 P1433 Q5421201 @default.
- Q91797066 P1476 "Evolving primary and secondary endpoints in randomized controlled trials leading to approval of biologics and small molecules in IBD: an historical perspective" @default.
- Q91797066 P2093 "Patrick B Allen" @default.
- Q91797066 P2093 "Stefanos Bonovas" @default.
- Q91797066 P304 "151-161" @default.
- Q91797066 P31 Q13442814 @default.
- Q91797066 P356 "10.1080/14712598.2020.1702020" @default.
- Q91797066 P433 "2" @default.
- Q91797066 P478 "20" @default.
- Q91797066 P50 Q30248039 @default.
- Q91797066 P50 Q89573798 @default.
- Q91797066 P577 "2020-02-01T00:00:00Z" @default.
- Q91797066 P698 "31815548" @default.